Taejon-si, South Korea

Yun Joo Park


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2002-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Yun Joo Park in Angiogenic Disease Treatment

Introduction

Yun Joo Park is a notable inventor based in Taejon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that target angiogenic diseases. With a total of 2 patents, his work focuses on innovative solutions for medical treatments.

Latest Patents

Yun Joo Park's latest patents include two groundbreaking inventions. The first patent involves a compound known as 7,8-dihydro-xanthenone-8-carboxylic acid derivative. This compound is useful for the prophylaxis and treatment of angiogenic diseases. It is produced by a novel microorganism, Aspergillus sp. Y80118, which was isolated from soil. This microorganism produces a compound that inhibits VEGF-induced proliferation of HUVEC, angiogenesis in CAM assay, and tumor growth. The second patent relates to isocoumarin derivatives that inhibit angiogenesis. This invention includes a method for preparing 6,8-dihydroxy-4-acetyl-isocoumarin from fungi, which is effective for treating various angiogenic diseases, including cancers, rheumatoid arthritis, and diabetic retinopathy.

Career Highlights

Yun Joo Park is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to focus on innovative research that has the potential to impact medical treatments significantly. His dedication to advancing biotechnology is evident in his patent filings and research contributions.

Collaborations

Yun Joo Park has collaborated with notable colleagues, including Jung Joon Lee and Jeong-Hyung Lee. These collaborations have fostered a productive research environment, leading to significant advancements in their field.

Conclusion

Yun Joo Park's innovative work in developing compounds for the treatment of angiogenic diseases showcases his commitment to advancing medical science. His contributions through patents and collaborations highlight the importance of research in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…